Patents by Inventor Stig Hansen

Stig Hansen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Methods for Identifying Compounds that Modulate Enzymatic Activities by Employing Covalently Bonded Target-Extender Complexes with Ligand Candidates
    Publication number: 20080220536
    Abstract: The present invention relates to the use of “tethering” to identify compounds that modulate enzymatic activity.
    Type: Application
    Filed: April 16, 2007
    Publication date: September 11, 2008
    Inventors: Daniel A. Erianson, Robert S. McDowell, Stig Hansen
  • Methods for identifying compounds that modulate enzymatic activities by employing covalently bonded target-extender complexes with ligand candidates
    Patent number: 7214487
    Abstract: The present invention relates to methods for identifying compounds that modulate enzymatic activity by contacting covalently bonded PTP-extender complexes or modified covalently bonded PTP-extender complexes with ligand candidates.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: May 8, 2007
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Daniel A. Erlanson, Robert S. McDowell, Stig Hansen
  • Battery charging method and apparatus therefor
    Publication number: 20050285568
    Abstract: By determining charging current Ichar and then subsequently utilising that determination of charging current Ichar in relation to battery current Ibat and load current Iload as a result of operation of a phone or other electronic device it is possible periodically to adjust the necessary charging current in order to operate the device in terms of recharging the battery to a target charging voltage, as well as providing adequate electrical current for operation of the associated phone or other electronic device.
    Type: Application
    Filed: June 25, 2004
    Publication date: December 29, 2005
    Inventors: Stig Hansen, Emil Froding, Frank Jorgensen
  • Compounds that modulate the activity of PTP-1B and TC-PTP
    Patent number: 6784205
    Abstract: The present invention relates to a new and improved method for treating diabetes and or its associated complications by modulating the activity of protein tryosin phosphatase 1B (“PTP-1B”). The inventive compounds modulate the activity PTP-1B by binding to a novel binding site referred herein as the PTP-1B exosite that is distal to the active site of PTP-1B. The present invention also relates to a new and improved method of treating immune system disorders by modulating the activity of T-cell protein tyrosine phosphatase (“TC-PTP”). The inventive compound modulate the activity of TC-PTP by binding to a novel binding site referred herein as the TC-PTP exosite that is distal to the active site of PTP-1B.
    Type: Grant
    Filed: February 25, 2003
    Date of Patent: August 31, 2004
    Assignee: Sunesis Pharmaceuticals, Inc.
    Inventors: Kenneth Barr, Bruce Fahr, Stig Hansen, Christian Wiesmann
  • Compounds that modulate the activity of PTP-1B and TC-PTP
    Publication number: 20040147596
    Abstract: The present invention relates to a new and improved method for treating diabetes and or its associated complications by modulating the activity of protein tryosin phosphatase 1B (“PTP-1B”). The inventive compounds modulate the activity PTP-1B by binding to a novel binding site referred herein as the PTP-1B exosite that is distal to the active site of PTP-1B. The present invention also relates to a new and improved method of treating immune system disorders by modulating the activity of T-cell protein tyrosine phosphatase (“TC-PTP”). The inventive compound modulate the activity of TC-PTP by binding to a novel binding site referred herein as the TC-PTP exosite that is distal to the active site of PTP-1B.
    Type: Application
    Filed: February 27, 2004
    Publication date: July 29, 2004
    Inventors: Kenneth Barr, Bruce Fahr, Stig Hansen, Christian Wiesmann
  • Methods for identifying compounds that modulate enzymatic activity
    Publication number: 20040005632
    Abstract: The present invention relates to the use of “tethering” to identify compounds that modulate enzymatic activity.
    Type: Application
    Filed: February 25, 2003
    Publication date: January 8, 2004
    Inventors: Daniel A. Erlanson, Robert S. McDowell, Stig Hansen
  • Compounds that modulate the activity of PTP-1B and TC-PTP
    Publication number: 20030195247
    Abstract: The present invention relates to a new and improved method for treating diabetes and.or its associated complications by modulating the activity of protein tryosin phosphatase 1B (“PTP-1B”). The inventive compounds modulate the activity PTP-1B by binding to a novel binding site referred herein as the PTP-1B exosite that is distal to the active site of PTP-1B. The present invention also relates to a new and improved method of treating immune system disorders by modulating the activity of T-cell protein tyrosine phosphatase (“TC-PTP”). The inventive compound modulate the activity of TC-PTP by binding to a novel binding site referred herein as the TC-PTP exosite that is distal to the active site of PTP-1B.
    Type: Application
    Filed: February 25, 2003
    Publication date: October 16, 2003
    Inventors: Kenneth Barr, Bruce Fahr, Stig Hansen, Christian Wiesmann
  • Method of using an antibody to the TN antigen for the inhibition of HIV infection
    Patent number: 5876716
    Abstract: A monoclonal or other antibody to the carbohydrate antigen Tn can be used to inhibit or slow the progression of AIDS or ARC. The antigen can be used in a vaccine, for immunisation.
    Type: Grant
    Filed: December 30, 1994
    Date of Patent: March 2, 1999
    Assignee: Bay Development Corporation SA
    Inventors: John-Erik Stig Hansen, Henrik Clausen